Showing results (51-60 of 149) with videos related to
Sort By:
Pageof 15
The Journal of Clinical Investigation|November 1, 1975
Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabeticsP Raskin, Y Fujita, R H UngerAnnals of Internal Medicine|October 1, 1981
Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitusF L Dunn, A Pietri, P RaskinDiabetes|March 1, 1976
Effect of insulin on the exaggerated glucagon response to arginine stimulation in diabetes mellitusP Raskin, I Aydin, R H UngerDiabetes Research and Clinical Practice|August 1, 1989
Insulin resistance and diabetes, mechanism and possible interventionM Koffler, L C Ramirez, P RaskinDiabetes|December 1, 1980
The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusionA Pietri, F L Dunn, P RaskinDiabetes|August 1, 1980
Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumpsA Pietri, A L Ehle, P RaskinAnnals of Internal Medicine|July 31, 1999
Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trialL Avilés-Santa, J Sinding, P RaskinDiabetes Care|January 1, 1995
A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDMW A Morgan, P Raskin, J RosenstockDiabetic Medicine : a Journal of the British Diabetic Association|February 23, 2008
Does serum 1,5-anhydroglucitol establish a relationship between improvements in HbA1c and postprandial glucose excursions? Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargineA C Moses, P Raskin, N KhutoryanskyDiabetes, Obesity & Metabolism|August 22, 2006
The visceral and subcutaneous fat changes in type 1 diabetes: a pilot studyA N Jacob, B Adams-Huet, P RaskinPageof 15